Among the control cohort, these patients are likely pursuing other interventions (e.g., lifestyle, diet, exercise) in addition to medications aside from GLP-1s that could lead them to see beneficial results
Generic and Biosimilar Versions In addition to the brand name Saxenda, lawsuits may also involve generic and biosimilar versions of GLP-1 receptor agonists that contain the same active ingredient
DHvR has acted as a consultant and received honoraria from Boehringer Ingelheim and Eli Lilly, MSD, Novo Nordisk, and Sanofi and has received research operating funds from Boehringer Ingelheim-Eli Lilly Diabetes Alliance, MSD, AstraZeneca, and Novo Nordisk
Comparison of isothiocyanate metabolite levels and histone deacetylase activity in human subjects consuming broccoli sprouts or broccoli supplement